We have previously compared the repopulation ability of gene-modified baboon CD34 + cells in an autologous transplantation versus a xenotransplant model in irradiated nonobese diabetic/severe combined immune deficiency (NOD/SCID) mice. Baboon CD34-selected marrow cells were transduced with a gammaretrovirus vector and infused into irradiated baboons and NOD/SCID mice. A limited integration-site analysis could only detect two common retrovirus integration sites in the NOD/SCID and monkey. Here, we performed locus-specific PCR on 30 clones recovered from NOD/SCID b2-microglobulin mice reconstituted with transduced baboon CD34 + cells. We identified five common integrants in the baboon early after transplant (2-6 weeks) but none during the long-term follow-up (6 and 12 months). These results confirm that repopulating cells in the NOD/SCID mouse contribute only to short-term repopulation in a clinically relevant large animal model.
Introduction
The nonobese diabetic/severe combined immune deficiency (NOD/SCID) xenotransplantation model is widely used as an assay to study human candidate stem cells. 1, 2 However, in contrast to large animal or human studies, the NOD/SCID model is limited by the short life span of the recipient, as well as the limited proliferative demand placed on transplanted cells and the inability to support differentiation into all hematopoietic lineages. In a previous study, we performed a direct comparison of the hematopoietic repopulation ability of transduced baboon CD34 + cells following autologous transplantation versus xenotransplantation in NOD/SCID mice. 3 A limited clonal analysis of the baboon and NOD/SCID repopulating cells revealed two retroviral integration sites present in both transplant models. This was the first evidence of a cell population relevant to a higher species, such as primate, with the ability to repopulate a NOD/ SCID xenotransplantation system. The two integrants were found early after transplant (6 weeks); however, no shared integration sites could be identified at a later stage (6 months), suggesting that the repopulating cells in the NOD/SCID mouse contributed only to short-term repopulation in the baboon.
In this study, we extended our previous work and analyzed 30 clones recovered from NOD/SCID b2-microglobulin (b2M) mice 6 weeks following transplant with baboon CD34 + cells. The cells were transduced with a genetic marker before infusion to allow their tracking by flow cytometry and PCR. Our objective was to determine whether the cell populations identified in the NOD/SCID b2M mice could be detected in baboon early (2-6 weeks) and/or late (6-12 months) after transplantation.
Study design
Gene transfer into CD34-enriched baboon cells
Baboon CD34-enriched cells were transduced with a Phoenix gibbon ape leukemia virus-pseudotyped gammaretrovirus vector MNDMFGeYFP. Mobilization, CD34 enrichment, transduction and transplantation were performed as previously described.
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Xenotransplantation of baboon CD34 + cells into NOD/SCID b2M null mice An aliquot of cells harvested from the transduction (2 Â 10 6 ) was transplanted into four 6-to 8-week-old sublethally irradiated (375 cGy) NOD/SCID b2M null mice (Jackson Laboratories, Bar Harbor, ME, USA). The remaining cells were reinfused into the irradiated baboon (1020 cGy total body irradiation), as previously described. 4 Six weeks after transplant, the mice were killed and bone marrow was analyzed for baboon cell engraftment by flow cytometry.
Linear amplification-mediated PCR
Linear amplification-mediated PCR analysis was performed from DNA extracted from mouse marrow and baboon peripheral blood samples, as previously described. 7 Successful integration sites obtained by linear amplification-mediated PCR samples were cloned into the pCR4 vector with the TOPO cloning kit (Invitrogen, Carlsbad, CA, USA) and incubated in large-format plates for automated colony picking and high-throughput processing at the University of Washington Genome Center. Sequences obtained were blasted against the most recent assembly of the human genome database using National Center for Biotechnology Information Blast. 8 Sequence candidates were considered potential insertion sites when they possessed X90% identity and a blast score 420.
PCR tracking of individual clones
To determine whether NOD/SCID b2M mice and baboon shared specific integration events, amplification of individual vector/flanking genomic DNA insertions from mice clones was analyzed by PCR in baboon peripheral blood DNA samples collected early (2-6 weeks) and late (6-12 months) after transplant and, as a control, in the DNA of the mouse from which the sequence was isolated. The PCRs were carried out using site-specific primers for each clone, along with primers that recognized the long terminal repeat (LTR) region adjacent to the genomic integration sites. Primers chosen from the genomic integration sites for NOD/SCID b2M mice clones are listed in 
Band recovery, reamplification, cloning and sequencing
When two or more PCR products had the same apparent molecular weight, the bands were excised from the gel, subcloned and analyzed by sequencing to verify their identity.
Results and discussion

Stable engraftment of genetically modified CD34 + cells in the baboon
We have previously reported efficient gene transfer to baboon repopulating cells using gibbon ape leukemia virus-pseudotyped vectors produced by a human packaging cell line based on 293T cells. 4 Here, we transduced baboon marrow CD34 + cells with a gammaretroviral Abbreviations: NOD/SCID, nonobese diabetic/severe combined immune deficiency; b2M, b2-microglobulin. +Sequence identified in NOD/SCID b2M bone marrow and detected in baboon peripheral blood.
ÀSequence identified in NOD/SCID b2M bone marrow and not detected in baboon peripheral blood.
Gene marking in mice and primates P Mezquita et al vector produced by the human Phoenix-gibbon ape leukemia virus/MNDMFGeYFP packaging cell line. Transduced cells were reinfused into the lethally irradiated baboon (2.3 Â 10 7 CD34 + cells per kg), and efficient marking was detected in all hematopoietic lineages over the following months. 9 Granulocytes carrying the transgene reached a maximum of 50% within 2 weeks (50%) and then declined to a lower yet stable level of 10%. 9 
Xenotransplantation of CD34-enriched baboon marrow cells into NOD/SCID b2M mice results in stable engraftment
An aliquot of transduced CD34-enriched cells was infused into four sublethally irradiated NOD/SCID b2M mice. Six weeks after transplantation, mice were killed and bone marrow samples were collected to determine the proportion of engrafted baboon cells expressing eYFP. The percentage of marked cells in the four animals ranged from 22 to 70%. 9 NOD/SCID b2M mice and baboon show only common retrovirus integration sites early after transplantation Linear amplification-mediated PCR analysis of retroviral integration sites revealed 30 clones in the NOD/SCID b2M mice carrying the eYFP transgene. The sequences of the integration sites were cloned, and specific primers were generated for these sequences (see Table 1 ). A locus-specific PCR analysis was performed on baboon peripheral blood DNA samples to determine whether the clones were present at different time points after transplantation. Baboon samples were analyzed early (2-6 weeks) and late (6-12 months) after transplantation. We identified five common integrants in the baboon early after transplant (2 weeks), two of which could still be detected at 6 weeks ( Figure 1) . None of the clones present in the NOD/SCID b2M mice, however, was found in the baboon during the long-term follow-up, 6 and 12 months post-transplant (Figure 1) .
These results are in accordance with our previous report on repopulation studies in NOD/SCID b2M mice and baboons following infusion of gene-modified baboon CD34 + cells. Only two common retroviral integration sites could be characterized at that time, both obtained 6 weeks after transplant. 3 Our present analysis found five NOD/SCID integration sites in the baboon early after transplantation (2-6 weeks); however, none could be detected at later time points (6-12 months). These findings confirm our previous observations and conclusions and suggest that the NOD/SCID repopulating cells are able to provide only short-term repopulation in the baboon. In addition, the levels of transduced cells in the NOD/SCID mice remained high and stable during the entire follow-up, whereas the percentage of cells carrying the transgene in baboon declined markedly 2-3 months following the transplant. This observation further supports the existence of a sub-population of cells, perhaps more easily transducible, which would provide repopulation in the NOD/SCID b2 mice, whereas a separate population would be responsible for providing long-term engraftment in the baboon. We have not performed secondary NOD/SCID transplants in these animals and thus cannot rule out that clones detected in secondary NOD/SCID transplants would result in longer and more durable engraftment in the baboons. In conclusion, our results emphasize the need to interpret the data in surrogate models with caution when predicting the behavior of human stem cells. This work was supported by National Institutes of Health grants HL54881, HL53750, DK47754, DK56465 and RR00166. Hans-Peter Kiem is a Markey Molecular Medicine investigator. Gene marking in mice and primates P Mezquita et al
